Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection
- PMID: 11342445
- DOI: 10.1182/blood.v97.10.3171
Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection
Abstract
Dendritic cells (DCs) are important for the initiation of immune responses to foreign antigens. Their antigen uptake and presentation capacities enable them to prime and activate T cells. Immature DCs capture antigens; however, they must be activated to mature before serving as efficient antigen-presenting cells. The antigen-presenting capacity of DCs can be diminished during viral infection and as a consequence of tumor formation. Chronic infection with hepatitis C virus (HCV) has been shown to affect the allostimulatory function of DCs. In this study, it is demonstrated that monocyte-derived DCs from patients with chronic HCV infection do not respond to maturation stimuli. Instead, they maintain their immature phenotype, reflected by the pattern of cell surface markers and by their continued capacity to uptake antigen. Moreover, their allostimulatory abilities are impaired compared with those of mature DCs derived from healthy donors. To investigate a possible correlation between viral clearance and this DC maturation defect, patients with resolved HCV infection after a course of antiviral therapy were studied. Results demonstrate that DCs from patients who cleared HCV behaved like DCs from healthy donors: in response to maturation stimuli, they decrease antigen uptake, up-regulate expression of appropriate surface markers, and are potent stimulators of allogeneic T cells. (Blood. 2001;97:3171-3176)
Similar articles
-
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors.J Hepatol. 2005 Jan;42(1):61-7. doi: 10.1016/j.jhep.2004.09.014. J Hepatol. 2005. PMID: 15629508
-
Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.Clin Exp Immunol. 2005 Nov;142(2):362-9. doi: 10.1111/j.1365-2249.2005.02919.x. Clin Exp Immunol. 2005. PMID: 16232225 Free PMC article.
-
Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells.Clin Exp Immunol. 2007 Jun;148(3):494-500. doi: 10.1111/j.1365-2249.2007.03367.x. Epub 2007 Mar 15. Clin Exp Immunol. 2007. PMID: 17362265 Free PMC article.
-
Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus.J Virol. 2004 Jun;78(12):6151-61. doi: 10.1128/JVI.78.12.6151-6161.2004. J Virol. 2004. PMID: 15163708 Free PMC article.
-
Dendritic cell gene therapy.Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. doi: 10.1016/s1055-3207(02)00027-3. Surg Oncol Clin N Am. 2002. PMID: 12487060 Review.
Cited by
-
Hepatitis C virus modified sE2F442NYT as an antigen in candidate vaccine facilitates human immune cell activation.J Virol. 2024 Jan 23;98(1):e0180923. doi: 10.1128/jvi.01809-23. Epub 2023 Dec 12. J Virol. 2024. PMID: 38084956 Free PMC article.
-
Hepatitis C and innate immunity: recent advances.Clin Liver Dis. 2008 Aug;12(3):675-92, x. doi: 10.1016/j.cld.2008.03.003. Clin Liver Dis. 2008. PMID: 18625434 Free PMC article.
-
Complement and viral pathogenesis.Virology. 2011 Mar 15;411(2):362-73. doi: 10.1016/j.virol.2010.12.045. Epub 2011 Feb 2. Virology. 2011. PMID: 21292294 Free PMC article. Review.
-
Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus.PLoS One. 2008 May 28;3(5):e2260. doi: 10.1371/journal.pone.0002260. PLoS One. 2008. PMID: 18509450 Free PMC article.
-
Plasma amino acids imbalance in cirrhotic patients disturbs the tricarboxylic acid cycle of dendritic cell.Sci Rep. 2013 Dec 10;3:3459. doi: 10.1038/srep03459. Sci Rep. 2013. PMID: 24322372 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources